Petra Naster

Antibiotics that worked yesterday may not work today as bacteria evolve and pathogens develop tools to resist treatment. Short courses can cure the underlying illness and save lives, yet we keep the newest drugs unused for confirmed or strongly suspected resistant infections to preserve treatment effectiveness. In our latest Vital Health Podcast, @DuaneSchulthess speaks with Henry Skinner (@AMRActionFund), joined by Joe Hammang, to explore the economics and policy that shape antibiotic innovation. The discussion explains how low clinical volumes collide with decade-long, high-cost development and how culture turnaround times of two to three days and the cost of advanced molecular tests limit diagnostic use even when long hospital stays drive far greater expense. The conversation also frames the market failure: new antibiotics often sit in reserve while development can cost about a billion dollars over many years, which creates a tragedy-of-the-commons dynamic that requires policy intervention. It highlights how the AMR Action Fund, formed by the @wellcometrust, the @WHO, and several pharmaceutical companies, is investing about $1B in clinical-stage biotechs to bring needed antibiotics through human trials. Listen: omny.fm/shows/vital-he… #AMR #Antibiotics #HealthPolicy #Diagnostics #Oncology #PublicHealth #AMRActionFund #Pharma #Biotech

Join us: @UMCUtrecht is looking for a PhD to reinforce their team for the project. All details here: academictransfer.com/nl/300901/post…

PODCAST: KU Leuven Launches Health Innovation Fellowship -> bit.ly/3qCzIUL @KU_Leuven @EITHealth

Event | The #iCONSENT guidelines to improve #informedconsent processes are ready for publication. Join us in "Towards the future of informed consent in clinical research", a virtual meeting to present them on March 16th 2021 at 16:00h Register here: conferenciasweb.es/i-consent/

Event | After 4 years of intense study we can now say that the #iCONSENT guidelines are ready for publication. Join us in "Towards the future of #informedconsent in clinical research", a virtual event to present them. Register and check the agenda i-consentproject.eu/towards-the-fu…

Trials@Home wants to understand the current knowledge of patients on RDCTs. Are you suffering from a chronic or rare disease and want to share? Please complete our survey: trialsathome.com/patient-survey/

REQUEST FOR PROPOSALS A Public Call for Proposals to build an end-to-end RDCT Tech Package -> all info and how to submit can be found here bit.ly/3aD1hZN -> deadline for submission 15 Jan 2021 @IMI_JU @radar_base @ECSEL_JU

PODCAST: Heidi Larson – Dispelling Vaccine Myths in the COVID-19 Era -> bit.ly/36KyIpM @ProfHeidiLarson @LSHTM @vaccine_trust @BSBHbyVT @DuaneSchulthess @VAC4EU

PODCAST with Hack Healthcare’s Leo Exter and Awell Health’s Thomas Vande Casteele -> bit.ly/3ll3r2E #valuebasedcare #valuebasedhealthcare #carepathways #HackHealthcare #HackBelgiumLabs #realworlddata @DuaneSchulthess @BSBHbyVT

PODCAST: Kees van Bochove, A Hyve in EHDEN -> bit.ly/3diPNtI @IMI_EHDEN @TheHyveNL @keesvanbochove @DuaneSchulthess @BSBHbyVT

PODCAST: Wilfred Reilly: "There is no empirical evidence for these lockdowns." -> bit.ly/3ghaE1U @wil_da_beast630 @DuaneSchulthess @BSBHbyVT

PODCAST: Dimitrios Athanasiou, a Duchenne Patient Advocate in the #COVIDー19 Era -> bit.ly/3fDp8J7 #Duchenne @dathax @worldduchenne @DuaneSchulthess @BSBHbyVT

Verrast uw baas u elke ochtend Jane Fonda-gewijs in een fluo lycra pakje voor een gezamenlijke workout? Hebt u uw snor recent in een pornovariant geschoren om de collega's te laten lachen tijdens de Zoom-meeting? Laat het ons weten! #Echobox=1587475154" target="_blank" rel="nofollow noopener">trends.knack.be/economie/style…

PODCAST: Adrian van den Hoven, Providing Europe’s COVID-19 Medicine Arsenal -> bit.ly/2XK5Hb0 @medicinesforEU @AdrianMEDSforEU @DuaneSchulthess @BSBHbyVT

PODCAST: BIO CEO @JimGreenwood, An Innovation Led Assault on #COVID19 -> bit.ly/34kE09T @IAmBiotech @DuaneSchulthess @BSBHbyVT

Remote and decentralised trials are the future – we know this now better than ever. Join #efpvirtual for free to hear expert speakers about our new, industry defining project, IMI Trials@Home. Register here -> bit.ly/2UiYLyf @IMI_JU @eyeforpharma @KaiLangel

Dealing with our #COVID-19 lockdown. Some of my thoughts on how about to deal with it based on my personal experience at sea.

Vital Health Podcast with Rick Grobbee - Trials@Home & Tribulations with COVID19 -> bit.ly/2UcRalW @DuaneSchulthess @BSBHbyVT @Grobbee @BigDataHeart @BD4BO @TrialsatHome @IMIGetReal #COVID19

Cambridge, MA based @moderna_tx is up and running with their Phase 1 trial for #COVID19. There is so much breakthrough science being thrown at this pandemic with pivotal findings it is staggering. God speed to biotech entrepreneurs!

Has a cure for #covid19 already been found? Amazing breakthrough in Australia repurposing an AIDS combo therapy cocktail in combination with a malaria drug. Given these are already approved therapies, this ‘cure’ could move very quickly to treatment. news.com.au/lifestyle/heal…